Table 1. Characteristics of migrants who accepted hepatitis B, hepatitis C and HIV^a screening during compulsory tuberculosis screening at public health services, the Netherlands 2013–2015 (n = 459).

	Total		Gelderland		Amsterdam		p value
	(n = 459)		(n = 203)		(n = 256)
	median	IQR	median	IQR	Median	IQR
Age (years)	29	26-35	28	25-34	30	27-36	< 0.001
	n	%	n	%	N	%
Sex
Male	211	45.97	92	45.32	119	46.48	0.804
Female	248	54.03	111	54.68	137	53.52
Reason for migration
Work or study	244	53.16	93	45.81	151	58.98	< 0.001
Other (e.g. family reunification)	162	35.29	110	54.19	52	20.31
Missing	53	11.55	0	0.00	53	20.70
Intended length of stay in the Netherlandsb
< 1 year	NA		19	9.36	NA		NA
1–2 years			28	13.79
> 2 years			116	57.14
Missing			40	19.70
Region of origin (categorised according to WHO regions)
South-East Asia	154	33.55	47	23.15	107	41.80	< 0.001
Europe (southern/eastern)	95	20.70	42	20.69	53	20.70
Western Pacific	86	18.74	42	20.69	44	17.19
Africa	61	13.29	32	15.76	29	11.33
Eastern Mediterranean	39	8.50	22	10.84	17	6.64
Americas (Latin America/Caribbean)	23	5.01	18	8.87	5	1.95
Missing	1	0.22	0	0.00	1	0.39
Estimated HBV prevalence (HBsAg-positive) in the country of originc
< 2%	204	44.44	66	32.51	138	53.91	< 0.001
≥ 2%	252	54.90	136	67.00	116	45.31
Missing	3	0.65	1	0.49	2	0.78
Estimated HCV prevalence (HCV-RNA positive) in the country of originc
< 2.5%	398	86.71	179	88.18	219	85.55	0.470
≥ 2.5%	60	13.07	24	11.82	36	14.06
Missing	1	0.22	0	0.00	1	0.39
Estimated HIV prevalence in the country of originc
< 2.12%	403	87.80	173	85.22	230	89.84	0.104
≥ 2.12%	55	11.98	30	14.78	25	9.77
Missing	1	0.22	0	0.00	1	0.39
Registered at a general practitioner in the Netherlandsd
No	NA		NA		174	67.97	NA
Yes					78	30.47
Missing					4	1.56
Registered for health insurance coverage in the Netherlandsd
No	NA		NA		72	28.13	NA
Yes, Dutch health insurance					122	47.66
Yes, foreign health insurance					27	10.55
Yes, student health insurance					10	3.91
Yes, but unknown which one					21	8.20
Missing					4	1.56

HBV: hepatitis B virus; HCV: hepatitis C virus; HIV: human immunodeficiency virus; IQR: interquartile range; NA: not applicable (not measured); WHO: World Health Organization.

^a HIV screening was included only in Amsterdam.

^b Measured only among participants from Gelderland.

^c Participants were grouped and categorised according to the estimated HBV, HCV and HIV prevalence reported by Schweitzer et al. [21], Gower et al. [22] and the Global Burden of Disease Study [23], respectively.

^d Measured only among participants from Amsterdam.

This table excludes migrants who accepted screening but in whom blood-drawing failed (n = 2).